PKBO — Peak Bio Balance Sheet
0.000.00%
- $0.22m
- $4.24m
- $0.61m
Annual balance sheet for Peak Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 0.35 | 0.205 | 0.655 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 0.634 | 0.459 | 3.23 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.536 | 0.381 | 4.06 |
Other Long Term Assets | |||
Total Assets | 1.33 | 1.08 | 7.53 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 1.8 | 2.79 | 10.8 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Liabilities | 1.92 | 3.01 | 15.6 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | -0.593 | -1.94 | -8.09 |
Total Liabilities & Shareholders' Equity | 1.33 | 1.08 | 7.53 |
Total Common Shares Outstanding |